Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.

Yang H, Ma L, Ma R, Huang D, Li W, Li J, Zhu Y, Wei L, Liu Z

Open source

DOI
10.31083/fbl54670
Published
2026 Oct 16
Container
Frontiers in bioscience (Landmark edition)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31083/fbl54670,
  title = {Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.},
  author = {Yang H and Ma L and Ma R and Huang D and Li W and Li J and Zhu Y and Wei L and Liu Z},
  year = {2026},
  journal = {Frontiers in bioscience (Landmark edition)},
  doi = {10.31083/fbl54670},
  url = {https://doi.org/10.31083/fbl54670}
}

RIS

TY  - JOUR
TI  - Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.
AU  - Yang H
AU  - Ma L
AU  - Ma R
AU  - Huang D
AU  - Li W
AU  - Li J
AU  - Zhu Y
AU  - Wei L
AU  - Liu Z
PY  - 2026
JO  - Frontiers in bioscience (Landmark edition)
DO  - 10.31083/fbl54670
UR  - https://doi.org/10.31083/fbl54670
ER  - 

APA

H, Y., L, M., R, M., D, H., W, L., J, L., Y, Z., L, W., & Z, L. (2026). Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.. Frontiers in bioscience (Landmark edition). https://doi.org/10.31083/fbl54670

Source records